Sponsored Links
| Sunovion Announces FDA Acceptance Of New Drug Application For Ciclesonide HFA Nasal Aerosol |
 |
 |
 |
| Medical News - Allergy | |||
|
Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration (FDA)... Read more: Allergy News From Medical News Today
|